Skip to main content

Table 1 The correlation between MENA expression levels and the clinical characteristics of the 119 HR+ breast cancer patients

From: Mammalian enabled protein enhances tamoxifen sensitivity of the hormone receptor-positive breast cancer patients by suppressing the AKT signaling pathway

Characteristic

Total (cases)

-MENA expression (cases)

χ2

P value

High

Low

All

119

83

36

  

Age (years)

 < 50

94

66

28

0.046

0.830

 ≥ 50

25

17

8

  

Tumor size

T1 + T2

97

68

29

0.031

0.859

T3 + T4

22

15

7

  

Local lymph node metastasis

N0

50

32

18

1.350

0.245

N1-N3

69

51

18

  

TNM stage

I + II

82

59

23

0.607

0.436

III

37

24

13

  

ER expression

0–1 + 

24

17

7

0.170

0.897

2–3 + 

95

66

29

  

Her-2 expression

Over express

35

25

10

0.066

0.797

Low express

84

58

26

  

Tumor classification

Luminal A

62

43

19

0.009

0.922

Luminal B + 

Her-2 overexpression (HR +)

57

40

17